| 608008 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Inhibitory effects of Paris saponin I, II, Ⅵ and Ⅶ on HUVEC cells through regulation of VEGFR2, PI3K/AKT/mTOR, Src/eNOS, PLCγ/ERK/MERK, and JAK2-STAT3 pathways |
2020-11-01 |
10.1016/j.biopha.2020.110750 |
Wang Wenping, Liu Yi, You Longtai, Sun Mingyi, Qu Changhai, Dong XiaoXv, Yin Xingbin, Ni Jian |
| 608007 |
BMJ OPEN |
Impact of allergic rhinitis on the day-to-day lives of children: insights from an Australian cross-sectional study |
2020-11-01 |
10.1136/bmjopen-2020-038870 |
Bosnic-Anticevich Sinthia, Smith Peter, Abramson Michael, Hespe Charlotte Mary, Johnson Menai, Stosic Rodney, Price David B |
| 608006 |
BMJ OPEN |
Urban–rural disparity in prevalence of multimorbidity in China: a cross-sectional nationally representative study |
2020-11-01 |
10.1136/bmjopen-2020-038404 |
Ma Xiaochen, He Yu, Xu Jin |
| 608005 |
CANCER MANAGEMENT AND RESEARCH |
miR-141 Promotes Colon Cancer Cell Proliferation by Targeted PHLPP2 Expression Inhibitionn |
2020-11-01 |
10.2147/cmar.s256670 |
Fang Fazhuang, Cheng Ling, Wu Xiaotang, Ye Minfeng, Zhang Huizhong |
| 608004 |
NEURO-ONCOLOGY |
NIMG-17. VALIDATION OF DIFFUSION MRI AS AN IMAGING BIOMARKER FOR BEVACIZUMAB THERAPY IN RECURRENT GLIOBLASTOMA IN A RANDOMIZED PHASE III TRIAL OF BEVACIZUMAB WITH OR WITHOUT VB-111 (GLOBE) | NIMG-17. VALIDATION OF DIFFUSION MRI AS AN IMAGING BIOMARKER FOR |
2020-11-01 |
10.1093/neuonc/noaa215.630 |
Ellingson Benjamin, Cloughesy Timothy, Wang Chencai, Patel Kunal, Raymond Catalina, Brenner Andrew, de Groot John, Butowski Nicholas, Zach Leor, Campian Jian, Schlossman Jacob, Rizvi Shan, Cohen Yael, Lowenton-Spier Noa, Minei Tamar Rachmilewitz, Fain-Shmueli Shifra, Wen Patrick |
| 608003 |
NEURO-ONCOLOGY |
TAMI-13. IMPORTANCE OF CD38 INHIBITION IN PRE-RECURRENT GLIOBLASTOMA | TAMI-13. IMPORTANCE OF CD38 INHIBITION IN PRE-RECURRENT GLIOBLASTOMA |
2020-11-01 |
10.1093/neuonc/noaa215.902 |
Hirte Renee, Olson Ian E, Rahman Masum, Mansour Moustafa, Casabella Amanda Munoz, Burns Terry C |
| 608002 |
NEURO-ONCOLOGY |
TMOD-34. PATIENT-DERIVED XENOGRAFT AND CELL LINE MODELS FACILITATE NOVEL TREATMENT DISCOVERY IN CENTRAL NERVOUS SYSTEM LYMPHOMAS | TMOD-34. PATIENT-DERIVED XENOGRAFT AND CELL LINE MODELS FACILITATE NOVEL TREATMENT DISCOVERY IN CENTRAL NERVOUS SYSTEM LYMPH |
2020-11-01 |
10.1093/neuonc/noaa215.984 |
Meredith David, Chow Kin Hoe, Kao Pei-Lun, Zeng Yu, Sinha Rileen, Shetty Aniket, Tolstorukov Michael, Tran Tony, Yerrum Smitha, Chukwueke Ugonma, Bi Wenya Linda, Arnaout Omar, Smith Timothy, Ligon Keith, Nayak Lakshmi |
| 608001 |
NEURO-ONCOLOGY |
BIOM-03. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES | BIOM-03. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES |
2020-11-01 |
10.1093/neuonc/noaa215.003 |
Dankner Matthew, Caron Maxime, Al-Saadi Tariq, Yu WenQing, Ouellet Veronique, Ezzeddine Rima, Annis Matthew G, Le Phuong Uyen, Nadaf Javad, Neubarth Noah S, Savage Paul, Zuo Dongmei, Couturier Charles P, Monlong Jean, Djambazian Haig, Altoukhi Huda, Bourque Guillaume, Ragoussis Jiannis, Diaz Roberto J, Park Morag, Guiot Marie-Christine, Lam Stephanie, Petrecca Kevin, Siegel Peter M |
| 608000 |
GYNECOLOGIC ONCOLOGY REPORTS |
Persistent complete hydatidiform molar pregnancy following assisted reproductive technology in a gestational carrier: Case report |
2020-11-01 |
10.1016/j.gore.2020.100646 |
Dzyubak Oleksandra, Lee Fritz Jamie, Taylor Taryn, McGee Jacob |
| 607999 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
776 A role for immune checkpoint blockade to enhance T cell-mediated responses in combination with chemotherapy in oesophageal adenocarcinoma |
2020-11-01 |
10.1136/jitc-2020-sitc2020.0776 |
Davern Maria, Lysaght Joanne, Sheppard Andrew, Maher Stephen, Donlon Noel, Reynolds John, Connell Fiona, Hayes Conall, King Ross, Bhardwaj Anshul |
